Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 18/20 | 0.78 |
| ▸ | DRD3 | P35462 | 18/20 | 0.78 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | DRD1 | P21728 | 1/20 | 0.54 |
| ▸ | DRD4 | P21917 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7854682 | 1.00 | DRD2 (0.78) | DRD2DRD3HDAC3HDAC1HDAC6 | |
| SCHEMBL7852040 | 0.91 | DRD2 (0.78) | DRD2DRD3 | |
| SCHEMBL7852036 | 0.91 | DRD2 (0.78) | DRD2DRD3 | |
| SCHEMBL7850789 | 0.91 | DRD2 (0.82) | DRD2DRD3 | |
| SCHEMBL7850791 | 0.91 | DRD2 (0.82) | DRD2DRD3 | |
| SCHEMBL7853775 | 0.89 | DRD2 (0.82) | DRD2DRD3 | |
| SCHEMBL7854513 | 0.89 | DRD2 (0.82) | DRD2DRD3 | |
| SCHEMBL7844129 | 0.88 | DRD2 (0.70) | DRD2DRD3HDAC3HDAC1HDAC6 | |
| SCHEMBL7843879 | 0.88 | DRD2 (0.70) | DRD2DRD3HDAC3HDAC1HDAC6 | |
| SCHEMBL7852348 | 0.88 | DRD2 (0.72) | DRD2DRD3HDAC3HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0922035-B1 | TETRAHYDROISOQUINOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | SMITHKLINE BEECHAM PLC (GB) | 2001-02-07 | — | — | EP | claimed |
| US-6143762-A | DRUGS AS DOPAMINE ANTAGONIST PSYCHOLOGICAL DISORDERS | SMITHKLINE BEECHAM, PLC (GB) | 2000-11-07 | — | — | US | claimed |
| EP-0922035-B1 | TETRAHYDROISOQUINOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | SMITHKLINE BEECHAM PLC (GB) | 2001-02-07 | — | — | EP | disclosed |
| US-6143762-A | DRUGS AS DOPAMINE ANTAGONIST PSYCHOLOGICAL DISORDERS | SMITHKLINE BEECHAM, PLC (GB) | 2000-11-07 | — | — | US | disclosed |